MedTrace Logo

Serum Citrate in Diagnosis and Follow-up for Glaucoma

NCT00804063 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2015-01-08

No results posted yet for this study

Summary

Glaucoma might be a mitochondria associated disease. Since citrate is a major component in mitochondrial metabolism its determination in blood might serve as a biomarker.

Conditions

Interventions

PROCEDURE

drawing blood sample

fasting blood sample

Sponsors & Collaborators

  • Kantonsspital Baselland Bruderholz

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • David Goldblum, MD · University Hospital, Basel, Switzerland

  • Josef Flammer, MD · University Hospital, Basel, Switzerland

  • Selim Orguel, MD · University Hospital, Basel, Switzerland

  • Stephan Fraenkl, MD · University Hospital, Basel, Switzerland

  • Fabrizio Branca, MD · University Basel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2012-12-31
Completion
2013-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00804063 on ClinicalTrials.gov